author_facet Bauerschmitz, Gerd J.
Guse, Kilian
Kanerva, Anna
Menzel, Artur
Herrmann, Isabell
Desmond, Renee A.
Yamamoto, Masato
Nettelbeck, Dirk M.
Hakkarainen, Tanja
Dall, Peter
Curiel, David T.
Hemminki, Akseli
Bauerschmitz, Gerd J.
Guse, Kilian
Kanerva, Anna
Menzel, Artur
Herrmann, Isabell
Desmond, Renee A.
Yamamoto, Masato
Nettelbeck, Dirk M.
Hakkarainen, Tanja
Dall, Peter
Curiel, David T.
Hemminki, Akseli
author Bauerschmitz, Gerd J.
Guse, Kilian
Kanerva, Anna
Menzel, Artur
Herrmann, Isabell
Desmond, Renee A.
Yamamoto, Masato
Nettelbeck, Dirk M.
Hakkarainen, Tanja
Dall, Peter
Curiel, David T.
Hemminki, Akseli
spellingShingle Bauerschmitz, Gerd J.
Guse, Kilian
Kanerva, Anna
Menzel, Artur
Herrmann, Isabell
Desmond, Renee A.
Yamamoto, Masato
Nettelbeck, Dirk M.
Hakkarainen, Tanja
Dall, Peter
Curiel, David T.
Hemminki, Akseli
Molecular Therapy
Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
Drug Discovery
Pharmacology
Genetics
Molecular Biology
Molecular Medicine
author_sort bauerschmitz, gerd j.
spelling Bauerschmitz, Gerd J. Guse, Kilian Kanerva, Anna Menzel, Artur Herrmann, Isabell Desmond, Renee A. Yamamoto, Masato Nettelbeck, Dirk M. Hakkarainen, Tanja Dall, Peter Curiel, David T. Hemminki, Akseli 1525-0016 Elsevier BV Drug Discovery Pharmacology Genetics Molecular Biology Molecular Medicine http://dx.doi.org/10.1016/j.ymthe.2006.01.010 Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells Molecular Therapy
doi_str_mv 10.1016/j.ymthe.2006.01.010
facet_avail Online
Free
finc_class_facet Biologie
Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9qLnltdGhlLjIwMDYuMDEuMDEw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9qLnltdGhlLjIwMDYuMDEuMDEw
institution DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
imprint Elsevier BV, 2006
imprint_str_mv Elsevier BV, 2006
issn 1525-0016
issn_str_mv 1525-0016
language English
mega_collection Elsevier BV (CrossRef)
match_str bauerschmitz2006tripletargetedoncolyticadenovirusesfeaturingthecox2promotere1atranscomplementationandserotypechimerismforenhancedselectivityforovariancancercells
publishDateSort 2006
publisher Elsevier BV
recordtype ai
record_format ai
series Molecular Therapy
source_id 49
title Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_unstemmed Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_full Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_fullStr Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_full_unstemmed Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_short Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_sort triple-targeted oncolytic adenoviruses featuring the cox2 promoter, e1a transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells
topic Drug Discovery
Pharmacology
Genetics
Molecular Biology
Molecular Medicine
url http://dx.doi.org/10.1016/j.ymthe.2006.01.010
publishDate 2006
physical 164-174
description
container_issue 2
container_start_page 164
container_title Molecular Therapy
container_volume 14
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792340206031994882
geogr_code not assigned
last_indexed 2024-03-01T16:00:20.448Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Triple-Targeted+Oncolytic+Adenoviruses+Featuring+the+Cox2+Promoter%2C+E1A+Transcomplementation%2C+and+Serotype+Chimerism+for+Enhanced+Selectivity+for+Ovarian+Cancer+Cells&rft.date=2006-08-01&genre=article&issn=1525-0016&volume=14&issue=2&spage=164&epage=174&pages=164-174&jtitle=Molecular+Therapy&atitle=Triple-Targeted+Oncolytic+Adenoviruses+Featuring+the+Cox2+Promoter%2C+E1A+Transcomplementation%2C+and+Serotype+Chimerism+for+Enhanced+Selectivity+for+Ovarian+Cancer+Cells&aulast=Hemminki&aufirst=Akseli&rft_id=info%3Adoi%2F10.1016%2Fj.ymthe.2006.01.010&rft.language%5B0%5D=eng
SOLR
_version_ 1792340206031994882
author Bauerschmitz, Gerd J., Guse, Kilian, Kanerva, Anna, Menzel, Artur, Herrmann, Isabell, Desmond, Renee A., Yamamoto, Masato, Nettelbeck, Dirk M., Hakkarainen, Tanja, Dall, Peter, Curiel, David T., Hemminki, Akseli
author_facet Bauerschmitz, Gerd J., Guse, Kilian, Kanerva, Anna, Menzel, Artur, Herrmann, Isabell, Desmond, Renee A., Yamamoto, Masato, Nettelbeck, Dirk M., Hakkarainen, Tanja, Dall, Peter, Curiel, David T., Hemminki, Akseli, Bauerschmitz, Gerd J., Guse, Kilian, Kanerva, Anna, Menzel, Artur, Herrmann, Isabell, Desmond, Renee A., Yamamoto, Masato, Nettelbeck, Dirk M., Hakkarainen, Tanja, Dall, Peter, Curiel, David T., Hemminki, Akseli
author_sort bauerschmitz, gerd j.
container_issue 2
container_start_page 164
container_title Molecular Therapy
container_volume 14
description
doi_str_mv 10.1016/j.ymthe.2006.01.010
facet_avail Online, Free
finc_class_facet Biologie, Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9qLnltdGhlLjIwMDYuMDEuMDEw
imprint Elsevier BV, 2006
imprint_str_mv Elsevier BV, 2006
institution DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14
issn 1525-0016
issn_str_mv 1525-0016
language English
last_indexed 2024-03-01T16:00:20.448Z
match_str bauerschmitz2006tripletargetedoncolyticadenovirusesfeaturingthecox2promotere1atranscomplementationandserotypechimerismforenhancedselectivityforovariancancercells
mega_collection Elsevier BV (CrossRef)
physical 164-174
publishDate 2006
publishDateSort 2006
publisher Elsevier BV
record_format ai
recordtype ai
series Molecular Therapy
source_id 49
spelling Bauerschmitz, Gerd J. Guse, Kilian Kanerva, Anna Menzel, Artur Herrmann, Isabell Desmond, Renee A. Yamamoto, Masato Nettelbeck, Dirk M. Hakkarainen, Tanja Dall, Peter Curiel, David T. Hemminki, Akseli 1525-0016 Elsevier BV Drug Discovery Pharmacology Genetics Molecular Biology Molecular Medicine http://dx.doi.org/10.1016/j.ymthe.2006.01.010 Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells Molecular Therapy
spellingShingle Bauerschmitz, Gerd J., Guse, Kilian, Kanerva, Anna, Menzel, Artur, Herrmann, Isabell, Desmond, Renee A., Yamamoto, Masato, Nettelbeck, Dirk M., Hakkarainen, Tanja, Dall, Peter, Curiel, David T., Hemminki, Akseli, Molecular Therapy, Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells, Drug Discovery, Pharmacology, Genetics, Molecular Biology, Molecular Medicine
title Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_full Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_fullStr Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_full_unstemmed Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_short Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
title_sort triple-targeted oncolytic adenoviruses featuring the cox2 promoter, e1a transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells
title_unstemmed Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells
topic Drug Discovery, Pharmacology, Genetics, Molecular Biology, Molecular Medicine
url http://dx.doi.org/10.1016/j.ymthe.2006.01.010